Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • etal
    Member
    • Oct 2013
    • 23

    #1

    Tumor-only variant calling

    I'm attempting to call SNVs in tumor samples without a paired normal sample. Some of these tumor samples can have low purity, so the allelic frequency of somatic variants is much lower than the .5 expected for germline SNPs. FreeBayes in particular gives these variants an extremely low quality score, even with the --pooled-continuous model, making it difficult to usefully filter the resulting VCF.

    Does anyone know of a good SNV caller designed for single tumor samples? Foundation Medicine claims to have built one, but did not release it publicly.

    Failing that: Can I fudge FreeBayes' --ploidy or --cnv-map arguments based on known tumor purity so that it will model any fully clonal somatic SNVs properly?

    This workflow looks like:
    1. Infer copy number segments from mapped reads (CNVkit).
    2. Infer tumor purity from segments (THetA).
    3. Compute fake tumor-cell ploidy = (2 / tumor_purity). Example: sample is 20% tumor cells; a somatic, heterozygous SNV that is fully clonal in the tumor cells would have allele frequency .1, so fake ploidy is 10.
    4. Rescale CNV values to fake ploidy, so neutral copy number is the fake ploidy value (e.g. 10). Round to integers.
    5. Run FreeBayes with --cnv-map = rescaled CNVs. (Also --pooled-discrete, I suppose.)


    Would this allow FreeBayes to accurately call somatic variants with appropriate quality scores?

    Could the same be done with GATK UnifiedGenotyper or HaplotypeCaller, or samtools?
  • etal
    Member
    • Oct 2013
    • 23

    #2
    Mentioned in another thread:

    Originally posted by SNPsaurus View Post
    You might try LoFreq for calling rarer variants:
    Download LoFreq for free. Fast and sensitive variant-calling from sequencing data. None

    http://www.ncbi.nlm.nih.gov/pubmed/23066108
    I think this is the sort of variant caller I was looking for.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 12:22 PM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    50 views
    0 reactions
    Last Post SEQadmin2  
    Working...